Priveterra Acquisition Corp. II Unit
PMGMU
PMGMU was delisted on the 18th of April, 2024.
5 hedge funds and large institutions have $330K invested in Priveterra Acquisition Corp. II Unit in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
104% more capital invested
Capital invested by funds: $161K → $330K (+$168K)
25% more funds holding
Funds holding: 4 → 5 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$88.4K |
| 2 |
VF
Virtu Financial
New York
|
+$58.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$14.8K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$708 |
PMGMU Hedge Fund Activity: Q3 2023 in Review
5 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Priveterra Acquisition Corp. II Unit (PMGMU) for Q3 2023, worth a combined $330K — up 104% from $161K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PMGMU positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Clear Street, adding an estimated $88.4K. The largest seller was Tower Research Capital (TRC), cutting an estimated $708.
- 5 institutional investors held Priveterra Acquisition Corp. II Unit (PMGMU) as of Q3 2023, up from 4 in Q2 2023.
- Funds reported $330K of Priveterra Acquisition Corp. II Unit stock for Q3 2023, up 104% quarter-over-quarter.
- 1 fund opened new Priveterra Acquisition Corp. II Unit positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Priveterra Acquisition Corp. II Unit buyer in Q3 2023 was Clear Street, an estimated $88.4K added.
- The largest Priveterra Acquisition Corp. II Unit seller in Q3 2023 was Tower Research Capital (TRC), an estimated $708 sold.
Based on aggregated 13F filings for Q3 2023.